Treatment of supratrochlear and supraorbital veins with long-pulsed 1064-nm Nd: YAG laser: A single-arm prospective pilot study.
Aline Faria Lamaita, Samantha Neves, Flávia Magalhães Silveira Magella Oliveira et al.
✦ AI-curated · Sources linked
In 30 seconds
This prospective, single-centre, single-arm pilot study assessed long-pulsed 1064-nm Nd:YAG laser treatment for visible supratrochlear and supraorbital veins in 10 adults. Participants received two treatment sessions, and outcomes included ultrasound measurements, blinded photographic assessments, safety, and patient satisfaction. Mean venous caliber decreased from 0.17 ± 0.05 cm to 0.12 ± 0.05 cm (p < 0.001). Blinded evaluators did not identify significant photographic differences, while no skin alterations were reported and nine patients (90%) rated results very good or excellent.
Key findings
- Ultrasound-measured venous caliber decreased from 0.17 ± 0.05 cm to 0.12 ± 0.05 cm (p < 0.001).
- Blinded evaluators found no significant difference between pre- and post-treatment photographs (κ = 0.176).
- No skin alterations occurred during the study.
- Nine patients (90%) rated results very good or excellent; none rated them poor or very poor.
Why it matters
The findings provide preliminary prospective evidence that laser treatment can reduce measured caliber of cosmetically undesirable forehead veins, with high reported patient satisfaction and no observed cutaneous changes in this small study. The lack of a detectable photographic difference highlights that an ultrasound change may not translate into a clearly visible improvement to blinded observers.
What to keep in mind
This was a single-centre, single-arm pilot study of 10 patients, without a comparator; blinded photographic assessments did not show significant differences.